The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma
- 1 August 2023
- journal article
- review article
- Published by SAGE Publications in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Vol. 36 (4) , 189-209
Abstract
The journey of using anticholinergics in the treatment of asthma started with anticholinergic-containing plants such as Datura stramonium and Atropa belladonna, followed by ipratropium bromide and continued with tiotropium, glycopyrronium, and umeclidinium. Although antimuscarinics were used in the maintenance treatment of asthma over a century ago, after a long time (since 2014), it has been recommended to be used as an add-on long-acting antimuscarinic agent (LAMA) therapy in the maintenance treatment of asthma. The airway tone controlled by the vagus nerve is increased in asthma. Allergens, toxins, or viruses cause airway inflammation and inflammation-related epithelial damage, increased sensory nerve stimulation, ganglionic and postganglionic acetylcholine (ACh) release by inflammatory mediators, intensification of ACh signaling at M1 and M3 muscarinic ACh receptors (mAChRs), and dysfunction of M2 mAChR. Optimal anticholinergic drug for asthma should effectively block M3 and M1 receptors, but have minimal effect on M2 receptors. Tiotropium, umeclidinium, and glycopyrronium are anticholinergic agents with this feature. Tiotropium has been used in a separate inhaler as an add-on treatment to inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA), and glycopyrronium and umeclidinium have been used in a single inhaler as a combination of ICS/LABA/LAMA in asthma in recent years. Guidelines recommend this regimen as an optimization step for patients with severe asthma before initiating any biologic or systemic corticosteroid therapy. In this review, the history of antimuscarinic agents, their effectiveness and safety in line with randomized controlled trials, and real-life studies in asthma treatment will be discussed according to the current data.Keywords
This publication has 110 references indexed in Scilit:
- Non‐bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea‐pig model of allergic asthmaBritish Journal of Pharmacology, 2011
- Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPDBritish Journal of Pharmacology, 2011
- Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled AsthmaNew England Journal of Medicine, 2010
- Increased parasympathetic tone as the underlying cause of asthma: A hypothesisMedical Hypotheses, 2010
- Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict responseAllergy, 2009
- Tiotropium bromide is effective for severe asthma with noneosinophilic phenotypeEuropean Respiratory Journal, 2008
- Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanismAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- EFFECT OF ACETYLCHOLINE AND MORPHINE ON BRONCHIAL SMOOTH MUSCLE CONTRACTION AND ITS MODULATION BY STEROID HORMONESClinical and Experimental Pharmacology and Physiology, 1990
- Role of the Parasympathetic System in Airway Obstruction Due to EmphysemaNew England Journal of Medicine, 1984